CCHR Condemns FDA’S Approval of Electricity-Zapping for “ADHD” Kids

CCHR Condemns FDA’S Approval of Electricity-Zapping for “ADHD” Kids

The Food and Drug Administration (FDA) has approved a device to zap a low-level electrical pulse through the forehead of 7-12 year olds as treatment for Attention Deficit Hyperactivity Disorder (ADHD).

CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections.

CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections.

The Citizens Commission on Human Rights is a non-profit mental health watchdog dedicated to the eradication of abuses committed under the guise of mental health.

The Citizens Commission on Human Rights is a non-profit mental health watchdog dedicated to the eradication of abuses committed under the guise of mental health.

Mental Health group says electrical “treatment” creates harm and the ongoing dangerous decisions by the FDA warrant a Congressional investigation.

The ongoing dangerous decisions by the FDA warrant a Congressional investigation.”

— Citizens Commission on Human Rights

CLEARWATER, FLORIDA, UNITED STATES, April 30, 2019 /EINPresswire.com/ — The Food and Drug Administration (FDA) has approved a device to zap a low-level electrical pulse through the forehead of 7-12 year olds as treatment for Attention Deficit Hyperactivity Disorder (ADHD). [1] But the mental health watchdog, Citizens Commission on Human Rights (CCHR), says that unsatisfied with the drugging of millions of children with mind-altering drugs associated with mania, psychosis, suicide and even death, psychiatrists have now turned to the FDA to approve a device that electro-shocks children into docility. This is yet another harmful psychiatric electricity-based practice being passed off as “therapy,” misleading parents into thinking their child will be “safe” undergoing it, CCHR says.

The Monarch eTNS System device costs around $1,000, according to CNN. A patch placed on the forehead uses a 9-volt lithium battery stimulation that creates a “tingling sensation” on the skin between the eyebrows. [2] Jan Eastgate, president of CCHR International says, “This latest practice of zapping a lack of focus sends a wrong message to children. Psychiatrists want them to believe that electricity pulsing through their brain while they sleep will help control impulsive behavior, despite no clinical study proving their behavior is a neurobiological condition.”

Recently, the FDA also cleared the usage of electroshock treatment—up to 460 volts of electricity through the brain—for adolescents aged 13 and above with “bipolar” disorder. Yet the FDA admits that it does not regulate medicine and therefore, how psychiatrists administer electroshock—a free-for-all license for committing “mental euthanasia” on any child, Eastgate adds. She called on people to sign CCHR’s petition to ban ECT

Freedom of Information requests CCHR filed in seven U.S. states reveal that psychiatrists are electroshocking kids aged five and younger.

Psychiatrists admit they don’t know how ECT “works.” Nor are there clinical studies proving safety and efficacy of ECT devices. Likewise, the exact mechanism of the Monarch eTNS System and its long-term effects is unknown. [3]

As Forbes pointed out: “There are nearly a dozen neurostimulation devices on the market that claim to improve cognitive function by allowing you to zap your brain with a small electrical current. But just because you can now do this at home doesn’t mean it’s a good idea. ECT uses electrical current in the range of 600-1000 milliamps…But you’re welcome to zap your brain with a much lighter touch of roughly 1-2 milliamps from the comfort of your couch for anywhere between $99 and $800 dollars. That is, if you don’t mind leaving the state of your brain up to chance.” [4]

The marketing hype fed parents for this new device is likely to go something like this: The “zapping” ADHD device is a “noninvasive treatment” and less risky that cocaine-like amphetamines or stimulants currently prescribed to treat “ADHD.” This avoids drug side effects like anorexia, poor growth and cardiovascular problems.

Jessica Baron, writing in Forbes noted, “While it’s true that the [neurostimulation] electrodes don’t penetrate your head, they must produce enough current to reach the brain in order to have any effect at all. Calling these products ‘noninvasive’ is merely a marketing technique and a misleading one if you ask me.” [5]

Researchers do not understand the effects of long-term use of brain stimulation, but say that no brain region exists in isolation. Modulating one brain area may impact on other areas. [6]

Nick J. Davis Ph.D. from the Department of Psychology, Swansea University, UK, explains that because the brain continues to develop until the age of 20, stimulation in children and adolescents would have a stronger impact.

Davis said there is evidence that enhancing one aspect of cognition may be detrimental to other cognitive faculties. “There is also the worrying possibility that electrical stimulation of the skull may induce or inhibit bone growth, an issue of particular importance in children whose cranial bones are not yet fused. This latter possibility has not been explored in human volunteers in brain stimulation experiments,” Davis wrote in 2014. [7]

Davis pleaded for “calm and caution” when opting for stimulation device use in children because serious effects of transcranial stimulation include seizure, mood changes or induction of hyper- or hypo-mania.

“For years, FDA has ignored the practice of psychiatrists electroshocking 0-5 year olds,” Eastgate said. Carlos Peña, Ph.D., Director, Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health, claims: “This new device offers a safe, non-drug option for treatment of ADHD in pediatric patients. He also fronted for the FDA when it reduced the risk classification of the brain-damaging ECT device, stating it was safe and effective, while not providing clinical trials from the manufacturers as evidence. Further, Peña was part of an FDA hearing in 2014 investigating the practice of aversive conditioning electrical devices to modify undesirable behavior. [8] In that case, FDA recommended a ban on a device used at the Judge Rotenberg Center in Massachusetts that zaps special-needs residents with an electric shock machine that delivers charges of up to 41 milliamps – 10 times the amperage used in most stun guns – to the body via electrodes on the skin. [9] To date, the FDA has not removed the device from the market. [10]

CCHR says ongoing dangerous decisions by the FDA warrant a Congressional investigation.

About CCHR: Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. L. Ron Hubbard, founder of Scientology, first brought psychiatric imprisonment to wide public notice: “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health,’” he wrote in March 1969. For more information visit www.cchrflorida.org

To View Source Information please visit https://www.cchrflorida.org/cchr-condemns-fdas-approval-of-electricity-zapping-for-adhd-kids/

Diane Stein
Citizens Commission on Human Rights of Florida
(727) 422-8820
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Electroconvulsive “Therapy” —The Facts about ECT


Source: EIN Presswire

Abraham Kiswani set to hit record fundraising total

Abraham Kiswani

Abraham Kiswani

Philanthropist and businessman Abraham Kiswani looks forward to setting a record total as this year's contributions get off to an unprecedented start.

BURBANK, ILLINOIS, USA, April 30, 2019 /EINPresswire.com/ — Well known and highly respected for his philanthropic nature and wider charitable efforts, security industry professional Abraham Kiswani and his business look set to reach a record donation and fundraising total in 2019 as the year gets off to a fantastic start. Here, Chicago-based Kiswani reveals more about his support for charities including the Make-A-Wish Foundation, Toys for Tots, and the Tuskegee NEXT project, as well as his commitment to other local good causes and initiatives.

Having raised many tens of thousands of dollars for charities and organizations including Toys for Tots, the Tuskegee NEXT project, St. Baldrick's, the Make-A-Wish Foundation, and St. Jude Children's Research Hospital in recent years, philanthropist Abraham Kiswani looks set to reach a record-breaking new total this year after donating more than $200,000 in 2018.

"Through fundraising, events, and donations made by myself and my company, we're looking to top last year's total in 2019," reveals Kiswani, who has already pledged significant sums of money to several of his preferred charities, nonprofit organizations, and other good causes this year. He currently estimates that this year's total could top $225,000.

Last month, Abraham Kiswani also announced details of the upcoming First Annual Beat Cancer Charity Basketball Showdown to be held in Chicago. Set to take place on Saturday, June 22, 2019, and billed as 'one of the best basketball showdowns the area has ever witnessed,' all proceeds from the event will be donated to St. Jude Children's Research Hospital.

One of Kiswani's most eagerly supported causes, the research hospital is closely tied to childhood cancer charity the St. Baldrick's Foundation, with which the businessman and philanthropist is also heavily involved.

Indeed, he and his company have donated annually to the charitable organization since 2012. Donations made by Kiswani and his firm solely to St. Baldrick's now exceed $35,000, he reveals. "Much like all of the good causes which I proudly support, St. Baldrick's is an incredible organization," he explains, "and entirely worthy of all the help and support that we can give."

A passionate sportsman, this year, Kiswani is also organizing a number of Major League Baseball tickets to generously gift to local disadvantaged children and those from low-income families. "We'll also continue to donate to Chicago's South Side churches to help feed the hungry and to further put back into the local community," adds the certified security sector professional, businessman, and philanthropist, wrapping up.

A graduate of Alan B. Shepard High School in Palos Heights, Illinois, Abraham Kiswani is today based in nearby Burbank, around 15 miles southwest of Chicago. Outside of his work and charitable efforts, Kiswani's personal interests include skydiving, bungee jumping, and antique muscle cars, as well as cooking, movie memorabilia collecting, sailing, scuba diving, and softball.

Caroline Hunter
Web Presence, LLC
+1 7865519491
email us here


Source: EIN Presswire

US Army Asymmetric Warfare Group to present at the Future Soldier Technology USA Conference 2019

Future Soldier Technology USA 2019

Future Soldier Technology USA 2019

SMi Reports: Strengthening Solider Lethality by Adapting to Complex and Asymmetric Threats will be discussed at Future Solider Technology USA this June.

LONDON, UNITED KINGDOM, April 30, 2019 /EINPresswire.com/ — The US Army is planning for future conflict in a mega-city environment, spending half a billion on specialized equipment and a model subterranean training center, to train its soldiers for underground combat.

“The Army’s Asymmetric Warfare Group – an outfit often tasked with looking ahead to identify future threats – told U.S. military leaders that special operations forces will not be able to deal with the subterranean problem alone and that large numbers of conventional forces must be trained and equipped to fight underground, the source said.” Source Task & Purpose June 25, 2018

Lieutenant Colonel Anthony Kurz, Squadron Commander, Asymmetric Warfare Group will present how they are enhancing future soldier capabilities at the Future Soldier Technology USA conference taking place in Arlington, VA on June 24th – 25th 2019.

His presentation “Strengthening Soldier Lethality by Adapting to Complex and Asymmetric Threats” will focus on:
• Contributing to soldier capability development through the work of the Asymmetric Warfare Group
• The need for agile response to new and complex threats in the 21st century battlefield to prepare soldiers for multi-domain operations
• Enhancing lethality and survivability for the dismounted soldier
• Identifying and bridging capability gaps through close work with partnership with other Army organisations

In line with the US Army’s modernization priority of increasing Soldier Lethality, Future Soldier Technology USA will bring together a community of senior military leaders, program managers, and researchers at the forefront of delivering enhanced soldier capabilities, from the US and beyond.

Latest attendees include: Asymmetric Warfare Group, BAE Systems, Department of Defence – Australia, FN America, FN Herstal, GLENAIR, Inc., Leonardo DRS, MCIA, Nexter Group, Radetec, Royal Marines, Secubit Ltd, Spearpoint Solutions & Technology Pty Ltd, U.S. Army Research Laboratory, Ultra Electronics US Army, US Army Test and Evaluation Command, USMC, USMC Training and Education Command, WL Gore, plus many more.

The event brochure with the two-day agenda can be downloaded at www.futuresoldierusa.com/ein

Future Soldier Technology USA is the only dedicated soldier and marine equipment modernisation conference in North America. With a unique focus on lightening the load and delivering greater lethality through advanced technology, this event will enable dismounted soldier and marine program managers to meet and test the latest equipment capable of enhancing infantry operations.

Places can be booked at www.futuresoldierusa.com/ein

If you are a US DoD: You will be granted free admission to the conference. However, in order to attend this event pre-registration is required, which is subject to final approval.

If you are from an international military or a commercial organisation, register on the event website.

Lead Sponsor: Glenair
Gold Sponsor: Black Diamond Advanced Technology and Leonardo DRS
Sponsors: FN America, Secubit and Ultra Electronics

For delegate enquiries, please contact James Hitchen on +44 (0) 20 7827 6054 / jhitchen@smi-online.co.uk

For sponsorship and exhibition packages available, contact Sadia Malick on +44 (0) 20 7827 6748 / smalick@smi-online.co.uk

Future Soldier Technology USA
Hilton Arlington, Virginia
June 24th – 25th 2019

About SMi: About SMi Group: Established since 1993, SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Shannon Cargan
SMi Group
+44 20 7827 6138
email us here


Source: EIN Presswire

Wrongful Conviction of a General Partner & Veteran who honorably served implicates New York State Judicial officials

Wrongful conviction of Veteran by New York State Judicial Official referred to Trump Administrations DOJ Civil Rights Division

It is well-settled law in New York State that Joint or Common owners to include General Partners, Limited Partners, Tenants in Common, Joint Owners cannot be charged or found guilty of larceny”

— L. Penn

NEW YORK, NY, UNITED STATES, April 30, 2019 /EINPresswire.com/ — Wrongful Conviction of a General Partner implicates Judicial Misconduct

New York State Officials and Supreme Court Justices Sued for Deprivation of Rights Under the Color of State Law

The City of New York, Manhattan District Attorney, Seven New York State Court Justices and other officials were sued for deprivation of rights under the color of law a civil violation under the law (42 U.S. Code § 1983) and a criminal violation under the law (18 U.S. Code § 242). The Civil Rights Complaints, Penn v. City of New York, et. al., 19-cv-02106 (under 42 U.S. Code § 1983) and Penn v. Amelia Cottrell, et. al., 19-cv-02741 (under Bivens) alleges that an indictment dated February 10, 2014 (New York Supreme Court Indictment #073/2014) and conviction of Lawrence E. Penn III, the Founder of Private Equity firm, The Camelot Group was unlawful from the very beginning. Civil Rights and Bivens actions allege that members of the Securities and Exchange Commission submitted a Complaint to the Manhattan District Attorney with false statements on January 30, 2014 resulting in an unlawful larceny-based indictment under the color of law in order to gain a civil case benefit by use of an unlawful conviction.

See full press release from PR Newswire: http://www.prnewswire.com/news-releases/new-york-state-officials-and-supreme-court-justices-sued-for-deprivation-of-rights-under-the-color-of-state-law-by-the-camelot-group-founder-300827895.html?tc=eml_cleartime

COURT OF APPEALS OF THE STATE OF NEW YORK CLARIFIED LARCENY STATUE BY DECLARATORY DECREE TO JUDGES AND PROSECUTORS: JOINT OR COMMON OWNERS CANNOT BE CHARGED OR FOUND GUILTY OF LARCENY

The lawsuits allege that the top count of larceny and the associated counts which rely on larceny are in direct violation of statutory and common law as decided by the Court of Appeals of the State of New York (the highest court in New York State) which ruled by declaratory decree over 25 years ago in long-established law in People v. Zinke, 556 N.Y.S.2d 11, 76 N.W.2d 8 (1990), that a “general partner in limited partnership cannot be found guilty of larceny for misappropriating partnership funds” because they are joint or common owners. Specifically, it is unlawful to charge a joint or common owner with interests in rights to distributions in limited partnership with larceny.

MR. PENN WAS A JOINT AND COMMON BENEFICIAL OWNER OF RIGHTS TO DISTRIBUTIONS FROM THE LIMITED PARTNERSHIP AND ACTING GENERAL PARTNER BY VIRTUE OF HIS INVESTED CAPITAL AND MANAGEMENT RIGHTS SIMILARLY SITUATED TO OTHERS

Mr. Penn, a joint and common beneficial owner with interests in rights to distributions in the limited partnership and the sole acting General Partner in the Limited Partnership called Camelot Acquisitions Secondary Opportunities, LP. Like other General Partners around the country, Mr. Penn established the Partnership, raised all the money, invested the capital, and met the contractual essence of the Partnership Agreement. The Complaints allege that the larceny-based indictment has no basis in law, was used to justify an arrest warrant and a bail of $2.5 million at arraignment as evidenced by Hearing Minutes.

The Securities and Exchange Commission acknowledges in a February 22, 2019 letter that, “From 2007 through 2014, he [Mr. Penn] was the general partner of Camelot Acquisitions Secondary Opportunities, LP (the Fund).” As part of Mr. Penn’s plea, he was required to forfeit his beneficial ownership in the partnership based on the money he put in the partnership. Obviously, you can’t forfeit something you do not own. Complaints alleges that the courts knew Mr. Penn was an owner and that his money was in the partnership.

MR. PENN WAS KNOWN AS A COMMUNITY LEADER WITH A SPOTLESS RECORD, MODEL CITIZEN WHO SUPPORTED VETERANS, WOMEN AND MINORITY CAUSES

The lawsuits allege Mr. Penn was detained in Manhattan Detention Center (MDC) for 14 months under the color of state law from February 10, 2014 to at least March 16, 2015, where a plea under the color of state law was entered. Mr. Penn states, “his plea and conviction are unconstitutionally void and invalid” because he was not informed of the law after direct inquiries to his defense attorney Benjamin Brafman. Prior to his incarceration, Mr. Penn had never been arrested, let alone detained or incarcerated. On the contrary, Mr. Penn is a former military officer who served honorably in the U.S. Army after graduation from the United States Military Academy at West Point with 3 masters’ degrees to include a Columbia MBA, executive education from Harvard, Peking, Oxford and Dartmouth, as well as 20 years of professional management, executive experience in private equity, mergers and acquisitions, and community leadership. He was one of the pioneer private equity secondary market.

LAWSUITS ALLEGE RECORD, FACTS AND LAW ARE CLEAR: NEW YORK OFFICE OF PERKINS COIE, LLP REPRESENTED MR. PENN PRO BONO FOR 2 YEARS REFUTING THE VALIDITY OF THE CONVICTION

Lawsuits allege that Appellate Division First Department’s ruling defies the record, facts, law and logic. as implied by. “Here, it is undisputed that Mr. Penn was the sole owner…of the ownership interest in the limited partnership. As such, Mr. Penn's conviction of larceny should be vacated, just as the defendant in Zinke's conviction of larceny was vacated by this Court.”

COMPLAINTS ALLEGE NON-JUDICIAL ACTIONS BY STATE JUDGES AND PROSECUTORS SHOWING THAT QUALIFIED AND ABSOLUTE IMMUNITY MUST FALL

The Complaints allege that both state and federal judges must uphold New York State law and declaratory decrees and that Federal Judges reliance on an unlawful conviction “on its face” is unconstitutional. Letters referring the cases to several federal and state officials were sent out to New York State legislators, Chief Judge Colleen McMahon of SDNY, U.S. Congressman Hakeem Jeffries of the Judiciary Committee, Department of Justice Civil Rights Division and President Trump.

The lawsuits bring to light unequal treatment of African-American litigants, wrongful convictions of U.S. veterans who honorably serve, the shortcomings of state level plea deals, unfair treatment of those who defend themselves, deprivations of immunities and privileges under long-established law as well as questions as to when immunity falls for state and federal prosecutorial and judicial officials.

Press inquiries can be sent to Goldman McCormick Public Relations at https://goldmanmccormick.com/ mark@goldmanmccormick.com, ryan@goldmanmccormick.com and press@thecamelotgroup.com.

Lawrence Penn
The Camelot Group
+1 917-582-8940
email us here


Source: EIN Presswire

HGSK Lawyer Appointed Vice Chair of Disciplinary Board of the PA Supreme Court

PHILADELPHIA, PA, UNITED STATES, April 29, 2019 /EINPresswire.com/ — +++

James C. Haggerty, Esquire, of Haggerty, Goldberg, Schleifer & Kupersmith has been appointed as Vice Chair of the Disciplinary Board of the Supreme Court of Pennsylvania.

The Disciplinary Board is a group of thirteen lawyers and laypersons appointed by the Supreme Court of Pennsylvania to supervise and oversee the disciplinary proceedings involving lawyers in the Commonwealth of Pennsylvania.

The Board was established to regulate attorney conduct. Their main goal is protecting the public while also preserving the reputation of courts in PA.

The Disciplinary Board appoints Hearing Board Examiners to hear cases involving attorneys, review the findings of the Hearing Board, and makes specific recommendations to the Supreme Court regarding punishment for attorneys violating the Rules of Disciplinary Enforcement and the Professional Code of Responsibility. The Disciplinary Enforcement rules were adopted by the Supreme Court in 1972, whereas the Professional Code in 1988.

Haggerty has served on the Board since 2015. His tenure as Vice Chair of the Board will be until April of 2020.

For more information contact Jim Haggerty at jhaggerty@hgsklawyers.com.

This release was drafted by Results Driven Marketing, LLC: a full-service digital marketing, public relations, advertising and content marketing firm located in Philadelphia, PA.

Related Materials:

https://www.hgsklawyers.com/News/2019/January/Tremendous-Supreme-Court-Victory.aspx

https://www.hgsklawyers.com/News/2018/December/Attorney-James-Haggerty-Awarded-2019-AV-Preemine.aspx

https://www.hgsklawyers.com/News/2018/October/HGSK-Sponsors-Upcoming-Bradbury-Sullivan-LGBT-Co.aspx

Jim Haggerty
HGSK
+1 267-419-6422
email us here


Source: EIN Presswire

Injectable Bags Market: Global Share, Size, Trends and Growth Analysis Forecast to 2019-2024

Wiseguyreports.Com Adds “Injectable Bags -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research Database

PUNE, MAHARASHTRA, INDIA, April 29, 2019 /EINPresswire.com/ — Injectable Bags Industry

Description

Injectable bags are used to provide life sustaining IV fluids, medications, and electrolytes to the patients. Through these bags, the intravenous therapy liquid directly enters into the vein and shows faster therapeutic action compared to oral therapy.

The global Injectable Bags market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. 

This report focuses on Injectable Bags volume and value at global level, regional level and company level. From a global perspective, this report represents overall Injectable Bags market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. 

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered: 

B.Braun Melsungen 
Otsuka Pharmaceutical India 
Kraton Corporation 
Hospira 
Haemotronic 
Baxter International 
Macopharma SA 
Medline Industries 
ICU Medical 
West Pharmaceutical Services

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3871029-global-injectable-bags-market-research-report-2019

Segment by Regions 
North America 
Europe 
China 
Japan

Segment by Type 
Polypropylene (PP) 
Polyvinylchloride (PVC) 
Ethylene Vinyl Acetate, 
PC 
Others Material Types

Segment by Application 
Blood Storage 
Blood transfusion 
Medications 
Electrolyte Imbalance

Leave a Query @ https://www.wiseguyreports.com/enquiry/3871029-global-injectable-bags-market-research-report-2019

Table of Contents

Executive Summary 
1 Injectable Bags Market Overview 
1.1 Product Overview and Scope of Injectable Bags 
1.2 Injectable Bags Segment by Type 
1.2.1 Global Injectable Bags Production Growth Rate Comparison by Type (2014-2025) 
1.2.2 Polypropylene (PP) 
1.2.3 Polyvinylchloride (PVC) 
1.2.4 Ethylene Vinyl Acetate, 
1.2.5 PC 
1.2.6 Others Material Types 
1.3 Injectable Bags Segment by Application 
1.3.1 Injectable Bags Consumption Comparison by Application (2014-2025) 
1.3.2 Blood Storage 
1.3.3 Blood transfusion 
1.3.4 Medications 
1.3.5 Electrolyte Imbalance 
1.4 Global Injectable Bags Market by Region 
1.4.1 Global Injectable Bags Market Size Region 
1.4.2 North America Status and Prospect (2014-2025) 
1.4.3 Europe Status and Prospect (2014-2025) 
1.4.4 China Status and Prospect (2014-2025) 
1.4.5 Japan Status and Prospect (2014-2025) 
1.5 Global Injectable Bags Market Size 
1.5.1 Global Injectable Bags Revenue (2014-2025) 
1.5.2 Global Injectable Bags Production (2014-2025)

2 Global Injectable Bags Market Competition by Manufacturers 
2.1 Global Injectable Bags Production Market Share by Manufacturers (2014-2019) 
2.2 Global Injectable Bags Revenue Share by Manufacturers (2014-2019) 
2.3 Global Injectable Bags Average Price by Manufacturers (2014-2019) 
2.4 Manufacturers Injectable Bags Production Sites, Area Served, Product Types 
2.5 Injectable Bags Market Competitive Situation and Trends 
2.5.1 Injectable Bags Market Concentration Rate 
2.5.2 Injectable Bags Market Share of Top 3 and Top 5 Manufacturers 
2.5.3 Mergers & Acquisitions, Expansion

….

7 Company Profiles and Key Figures in Injectable Bags Business 
7.1 B.Braun Melsungen 
7.1.1 B.Braun Melsungen Injectable Bags Production Sites and Area Served 
7.1.2 Injectable Bags Product Introduction, Application and Specification 
7.1.3 B.Braun Melsungen Injectable Bags Production, Revenue, Price and Gross Margin (2014-2019) 
7.1.4 Main Business and Markets Served 
7.2 Otsuka Pharmaceutical India 
7.2.1 Otsuka Pharmaceutical India Injectable Bags Production Sites and Area Served 
7.2.2 Injectable Bags Product Introduction, Application and Specification 
7.2.3 Otsuka Pharmaceutical India Injectable Bags Production, Revenue, Price and Gross Margin (2014-2019) 
7.2.4 Main Business and Markets Served 
7.3 Kraton Corporation 
7.3.1 Kraton Corporation Injectable Bags Production Sites and Area Served 
7.3.2 Injectable Bags Product Introduction, Application and Specification 
7.3.3 Kraton Corporation Injectable Bags Production, Revenue, Price and Gross Margin (2014-2019) 
7.3.4 Main Business and Markets Served 
7.4 Hospira 
7.4.1 Hospira Injectable Bags Production Sites and Area Served 
7.4.2 Injectable Bags Product Introduction, Application and Specification 
7.4.3 Hospira Injectable Bags Production, Revenue, Price and Gross Margin (2014-2019) 
7.4.4 Main Business and Markets Served 
7.5 Haemotronic 
7.5.1 Haemotronic Injectable Bags Production Sites and Area Served 
7.5.2 Injectable Bags Product Introduction, Application and Specification 
7.5.3 Haemotronic Injectable Bags Production, Revenue, Price and Gross Margin (2014-2019) 
7.5.4 Main Business and Markets Served 
7.6 Baxter International 
7.6.1 Baxter International Injectable Bags Production Sites and Area Served 
7.6.2 Injectable Bags Product Introduction, Application and Specification 
7.6.3 Baxter International Injectable Bags Production, Revenue, Price and Gross Margin (2014-2019) 
7.6.4 Main Business and Markets Served 
7.7 Macopharma SA 
7.7.1 Macopharma SA Injectable Bags Production Sites and Area Served 
7.7.2 Injectable Bags Product Introduction, Application and Specification 
7.7.3 Macopharma SA Injectable Bags Production, Revenue, Price and Gross Margin (2014-2019) 
7.7.4 Main Business and Markets Served 
7.8 Medline Industries 
7.8.1 Medline Industries Injectable Bags Production Sites and Area Served 
7.8.2 Injectable Bags Product Introduction, Application and Specification 
7.8.3 Medline Industries Injectable Bags Production, Revenue, Price and Gross Margin (2014-2019) 
7.8.4 Main Business and Markets Served 
7.9 ICU Medical 
7.9.1 ICU Medical Injectable Bags Production Sites and Area Served 
7.9.2 Injectable Bags Product Introduction, Application and Specification 
7.9.3 ICU Medical Injectable Bags Production, Revenue, Price and Gross Margin (2014-2019) 
7.9.4 Main Business and Markets Served 
7.10 West Pharmaceutical Services 
7.10.1 West Pharmaceutical Services Injectable Bags Production Sites and Area Served 
7.10.2 Injectable Bags Product Introduction, Application and Specification 
7.10.3 West Pharmaceutical Services Injectable Bags Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3871029

Continued…                       

 

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Food Allergy Immunotherapies Market 2019: Global Analysis, Share, Trends, Application Analysis and Forecast To 2024

Food Allergy Immunotherapies -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024

PUNE, MAHARASHTRA, INDIA, April 29, 2019 /EINPresswire.com/ — Food Allergy Immunotherapies Industry

Description

Wiseguyreports.Com Adds “Food Allergy Immunotherapies -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research Database

Food allergy is an immune system reaction that occurs soon after eating a certain food. 
In 2018, the global Food Allergy Immunotherapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Food Allergy Immunotherapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Food Allergy Immunotherapies development in United States, Europe and China.

The key players covered in this study 

Anergis 
HAL Allergy Group 
Merck 
Stallergenes Greer 
Laboratorios LETI 

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3870840-global-food-allergy-immunotherapies-market-size-status-and-forecast-2019-2025

Market segment by Type, the product can be split into 
Subcutaneous Immunotherapy 
Sublingual Immunotherapy

Market segment by Application, split into 
Hospital Pharmacies 
Online Pharmacies 
Retail Pharmacies

Market segment by Regions/Countries, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India 
Central & South America

The study objectives of this report are: 
To analyze global Food Allergy Immunotherapies status, future forecast, growth opportunity, key market and key players. 
To present the Food Allergy Immunotherapies development in United States, Europe and China. 
To strategically profile the key players and comprehensively analyze their development plan and strategies. 
To define, describe and forecast the market by product type, market and key regions.

Leave a Query @ https://www.wiseguyreports.com/enquiry/3870840-global-food-allergy-immunotherapies-market-size-status-and-forecast-2019-2025

Table of Contents

1 Report Overview 
1.1 Study Scope 
1.2 Key Market Segments 
1.3 Players Covered 
1.4 Market Analysis by Type 
1.4.1 Global Food Allergy Immunotherapies Market Size Growth Rate by Type (2014-2025) 
1.4.2 Subcutaneous Immunotherapy 
1.4.3 Sublingual Immunotherapy 
1.5 Market by Application 
1.5.1 Global Food Allergy Immunotherapies Market Share by Application (2014-2025) 
1.5.2 Hospital Pharmacies 
1.5.3 Online Pharmacies 
1.5.4 Retail Pharmacies 
1.6 Study Objectives 
1.7 Years Considered

2 Global Growth Trends 
2.1 Food Allergy Immunotherapies Market Size 
2.2 Food Allergy Immunotherapies Growth Trends by Regions 
2.2.1 Food Allergy Immunotherapies Market Size by Regions (2014-2025) 
2.2.2 Food Allergy Immunotherapies Market Share by Regions (2014-2019) 
2.3 Industry Trends 
2.3.1 Market Top Trends 
2.3.2 Market Drivers 
2.3.3 Market Opportunities

….

12 International Players Profiles 
12.1 Anergis 
12.1.1 Anergis Company Details 
12.1.2 Company Description and Business Overview 
12.1.3 Food Allergy Immunotherapies Introduction 
12.1.4 Anergis Revenue in Food Allergy Immunotherapies Business (2014-2019) 
12.1.5 Anergis Recent Development 
12.2 HAL Allergy Group 
12.2.1 HAL Allergy Group Company Details 
12.2.2 Company Description and Business Overview 
12.2.3 Food Allergy Immunotherapies Introduction 
12.2.4 HAL Allergy Group Revenue in Food Allergy Immunotherapies Business (2014-2019) 
12.2.5 HAL Allergy Group Recent Development 
12.3 Merck 
12.3.1 Merck Company Details 
12.3.2 Company Description and Business Overview 
12.3.3 Food Allergy Immunotherapies Introduction 
12.3.4 Merck Revenue in Food Allergy Immunotherapies Business (2014-2019) 
12.3.5 Merck Recent Development 
12.4 Stallergenes Greer 
12.4.1 Stallergenes Greer Company Details 
12.4.2 Company Description and Business Overview 
12.4.3 Food Allergy Immunotherapies Introduction 
12.4.4 Stallergenes Greer Revenue in Food Allergy Immunotherapies Business (2014-2019) 
12.4.5 Stallergenes Greer Recent Development 
12.5 Laboratorios LETI 
12.5.1 Laboratorios LETI Company Details 
12.5.2 Company Description and Business Overview 
12.5.3 Food Allergy Immunotherapies Introduction 
12.5.4 Laboratorios LETI Revenue in Food Allergy Immunotherapies Business (2014-2019) 
12.5.5 Laboratorios LETI Recent Development

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3870840

Continued…                       

 

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Mobile Backhaul & Fronthaul Market 2019: Global Analysis, Share, Trends, Application Analysis and Forecast To 2024

Mobile Backhaul & Fronthaul -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024

PUNE, MAHARASHTRA, INDIA, April 29, 2019 /EINPresswire.com/ — Mobile Backhaul & Fronthaul Industry

Description

The mobile front end interfacing part of the cellular network is known as mobile fronthaul, and the back end part of cellular network which connects fronthaul with voice/data circuits is known as Mobile backhaul.

The Global Mobile Backhaul & Fronthaul market is expected to increase to $40143.04 million by 2026 from $12121.20 million in 2019, growing at a CAGR of 18.66% from 2019 to 2026.

The major players in global Mobile Backhaul & Fronthaul market include 

Cisco 
Nokia Networks(Alcatel-Lucent) 
Ericsson 
Huawei Technologies 
Broadcom 
Ciena 
Fujitsu 
Infinera 
Omnitron Systems 
ZTE 
LS Networks

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3883703-global-mobile-backhaul-fronthaul-market-insights-forecast-to-2025

Geographically, this report is segmented into several key regions, with revenue, market share and growth rate of Mobile Backhaul & Fronthaul in these regions, from 2014 to 2026 (forecast), covering 
United States 
EU 
Japan 
India 
China 
Southeast Asia 
Central & South America 
ROW

On the basis of product, the Mobile Backhaul & Fronthaul market is primarily split into 
Mobile Backhaul 
Mobile Fronthaul

On the basis on the applications, this report covers 
Telecommunications 
Networking 
Government 
Enterprises 
Other

Leave a Query @ https://www.wiseguyreports.com/enquiry/3883703-global-mobile-backhaul-fronthaul-market-insights-forecast-to-2025

Table of Contents

1 Report Overview 1 
    1.1 Study Scope 1 
    1.2 Key Market Segments 2 
    1.3 Players Covered 2 
    1.4 Market Analysis by Type 3 
    1.5 Market by Application 4 
    1.6 Study Objectives 6 
    1.7 Years Considered 7 

2 Global Growth Trends 8 
    2.1 Global Mobile Backhaul & Fronthaul Market Size 8 
    2.2 Mobile Backhaul & Fronthaul Growth Trends by Regions 9 
      2.2.1 Mobile Backhaul & Fronthaul Market Size by Regions (2014-2025) 9 
      2.2.2 Mobile Backhaul & Fronthaul Market Share by Regions (2014-2019) 9 
    2.3 Industry Trends 11 
      2.3.1 Market Drivers 11 
      2.3.2 Market Challenges 11 
      2.3.3 Technology Development Trend 12

….

12 International Players Profiles 51 
    12.1 Cisco (US) 51 
      12.1.1 Company Profile 51 
      12.1.2 Products, Services and Solutions 52 
      12.1.3 Cisco Mobile Backhaul & Fronthaul Revenue (Million USD) (2014-2019) 54 
      12.1.4 Contact Information 55 
    12.2 Nokia Networks (Alcatel-Lucent) (FI) 55 
      12.2.1 Company Profile 55 
      12.2.2 Products, Services and Solutions 56 
      12.2.3 Nokia Networks Mobile Backhaul & Fronthaul Revenue (Million USD) (2014-2019) 57 
      12.2.4 Contact Information 59 
    12.3 Ericsson (SE) 59 
      12.3.1 Company Profile 59 
      12.3.2 Products, Services and Solutions 60 
      12.3.3 Ericsson Mobile Backhaul & Fronthaul Revenue (Million USD) (2014-2019) 62 
      12.3.4 Contact Information 63 
    12.4 Huawei Technologies (CN) 63 
      12.4.1 Company Profile 63 
      12.4.2 Products, Services and Solutions 64 
      12.4.3 Huawei Technologies Mobile Backhaul & Fronthaul Revenue (Million USD) (2014-2019) 65 
      12.4.4 Contact Information 67 
    12.5 Broadcom (US) 67 
      12.5.1 Company Profile 67 
      12.5.2 Products, Services and Solutions 68 
      12.5.3 Broadcom Mobile Backhaul & Fronthaul Revenue (Million USD) (2014-2019) 69 
      12.5.4 Contact Information 70 
    12.6 Ciena (US) 70 
      12.6.1 Company Profile 70 
      12.6.2 Products, Services and Solutions 71 
      12.6.3 Ciena Mobile Backhaul & Fronthaul Revenue (Million USD) (2014-2019) 71 
      12.6.4 Contact Information 73 
    12.7 Fujitsu (JP) 73 
      12.7.1 Company Profile 73 
      12.7.2 Products, Services and Solutions 74 
      12.7.3 Fujitsu Mobile Backhaul & Fronthaul Revenue (Million USD) (2014-2019) 76 
      12.7.4 Contact Information 77 
    12.8 Infinera (US) 77 
      12.8.1 Company Profile 77 
      12.8.2 Products, Services and Solutions 79 
      12.8.3 Infinera Mobile Backhaul & Fronthaul Revenue (Million USD) (2014-2019) 80 
      12.8.4 Contact Information 81 
    12.9 Omnitron Systems (US) 82 
      12.9.1 Company Profile 82 
      12.9.2 Products, Services and Solutions 82 
      12.9.3 Omnitron Systems Mobile Backhaul & Fronthaul Revenue (Million USD) (2014-2019) 84 
      12.9.4 Contact Information 85 
    12.10 ZTE (CN) 85 
      12.10.1 Company Profile 85 
      12.10.2 Products, Services and Solutions 86 
      12.10.3 ZTE Mobile Backhaul & Fronthaul Revenue (Million USD) (2014-2019) 87 
      12.10.4 Contact Information 88 
    12.11 LS Networks (US) 89 
      12.11.1 Company Profile 89 
      12.11.2 Products, Services and Solutions 89 
      12.11.3 LS Networks Mobile Backhaul & Fronthaul Revenue (Million USD) (2014-2019) 90 
      12.11.4 Contact Information 91 

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3883703

Continued…                       

 

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Plant Based Protein Supplements Market 2019: Global Analysis, Share, Trends, Application Analysis and Forecast To 2024

Plant Based Protein Supplements -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024

PUNE, MAHARASHTRA, INDIA, April 29, 2019 /EINPresswire.com/ — Plant Based Protein Supplements Industry

Description

Protein is an important part of a healthy diet and animal sources are the most common choice. But Many people choose plant based protein as opposed to dairy-based powders (whey or casein) due to lactose intolerance or sensitivity to dairy proteins. 
Rising importance of a vegan diet as a result of the risk of cardiovascular diseases and type 2 diabetes associated with the consumption of meat products is expected to have a strong positive impact on the growth.

The global Plant Based Protein Supplements market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Plant Based Protein Supplements market based on company, product type, end user and key regions.

This report studies the global market size of Plant Based Protein Supplements in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Plant Based Protein Supplements in these regions. 

This research report categorizes the global Plant Based Protein Supplements market by top players/brands, region, type and end user. This report also studies the global Plant Based Protein Supplements market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company: 

Glanbia plc 
NOW Foods 
MusclePharm Corporation 
CytoSport, Inc. 
Quest 
NBTY 
AMCO Proteins 
Abbott Laboratories 
IOVATE Health Sciences International, Inc 
Transparent Labs

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3883709-global-plant-based-protein-supplements-market-insights-forecast-to-2025

Market size by Product 
Soy 
Spirulina 
Pumpkin Seed 
Hemp 
Rice 
Pea 
Others 

Market size by End User 
Protein Powder 
Protein Bars 
Ready- to-Drink (RTD) 
Others

Market size by Region 
North America 
United States 
Canada 
Mexico 
Asia-Pacific 
China 
India 

The study objectives of this report are: 
To study and analyze the global Plant Based Protein Supplements market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. 
To understand the structure of Plant Based Protein Supplements market by identifying its various subsegments. 
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). 
Focuses on the key global Plant Based Protein Supplements companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. 
To project the value and sales volume of Plant Based Protein Supplements submarkets, with respect to key regions. 
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Leave a Query @ https://www.wiseguyreports.com/enquiry/3883709-global-plant-based-protein-supplements-market-insights-forecast-to-2025

Table of Contents

1 Study Coverage 
1.1 Plant Based Protein Supplements Product 
1.2 Market Segments 
1.3 Key Manufacturers Covered 
1.4 Market by Type 
1.4.1 Global Plant Based Protein Supplements Market Size Growth Rate by Product 
1.4.2 Soy 
1.4.3 Spirulina 
1.4.4 Pumpkin Seed 
1.4.5 Hemp 
1.4.6 Rice 
1.4.7 Pea 
1.4.8 Others 
1.5 Market by End User 
1.5.1 Global Plant Based Protein Supplements Market Size Growth Rate by End User 
1.5.2 Protein Powder 
1.5.3 Protein Bars 
1.5.4 Ready- to-Drink (RTD) 
1.5.5 Others 
1.6 Study Objectives 
1.7 Years Considered

2 Executive Summary 
2.1 Global Plant Based Protein Supplements Market Size 
2.1.1 Global Plant Based Protein Supplements Revenue 2014-2025 
2.1.2 Global Plant Based Protein Supplements Sales 2014-2025 
2.2 Plant Based Protein Supplements Growth Rate by Regions 
2.2.1 Global Plant Based Protein Supplements Sales by Regions 
2.2.2 Global Plant Based Protein Supplements Revenue by Regions

….

11 Company Profiles 
11.1 Glanbia plc 
11.1.1 Glanbia plc Company Details 
11.1.2 Company Business Overview 
11.1.3 Glanbia plc Plant Based Protein Supplements Sales, Revenue and Gross Margin (2014-2019) 
11.1.4 Glanbia plc Plant Based Protein Supplements Products Offered 
11.1.5 Glanbia plc Recent Development 
11.2 NOW Foods  
11.3 MusclePharm Corporation 
11.4 CytoSport, Inc. 
11.5 Quest 
11.6 NBTY 
11.7 AMCO Proteins 
11.8.1 Abbott Laboratories Company Details 
11.9 IOVATE Health Sciences International, Inc 
11.10 Transparent Labs 

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3883709

Continued…                       

 

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Smart Mattress Market: Global Analysis,Share, Trends, Application Analysis And Forecast To 2024

Wiseguyreports.Com Adds “Smart Mattress -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research Database

PUNE, MAHARASHTRA, INDIA, April 29, 2019 /EINPresswire.com/ — Smart Mattress Industry

Description

Smart mattress is a loose term referring to any mattress model with sensor technology designed to monitor the sleep patterns and routines of its owner(s). Today’s smart mattresses can track how long a person sleeps and the duration of their REM cycles, as well as physiological factors like body temperature, heart rate, and breathing. Other functions of a smart mattress may include alarms, adjustable climate control, and internet connectivity. Additionally, some smart airbeds enable owners to adjust the firmness settings of their sleep surface using remote controls. 

In the coming years there is an increasing demand for Smart Mattress in the regions of North America and Europe that is expected to drive the market for more advanced Smart Mattress. Growth in government budgets in the principal countries, increasing of residential fields expenditures, more-intense competition, launches in introducing new products, retrofitting and renovation of old technology, increasing adoption of Smart Mattress will drive growth in North America and Europe markets. 

Globally, the Smart Mattress industry market is concentrated as the manufacturing technology of Smart Mattress is relatively matures than some high-tech equipment. And some enterprises, like Sleep Number, Eight Sleep, ReST etc. are well-known for the wonderful performance of their Smart Mattress and related services. At the same time, North America, occupied 81% sales market share in 2017, is remarkable in the global Smart Mattress industry because of their market share and technology status of Smart Mattress. 

The product average price declined in the past few years due to the technology development, the average price will keep the trend in the few future years due to increasing mature manufacturing technology and lowing cost of raw materials. 

The global Smart Mattress market is valued at 130 million US$ in 2018 and will reach 2550 million US$ by the end of 2025, growing at a CAGR of 52.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Smart Mattress market based on company, product type, end user and key regions.

This report studies the global market size of Smart Mattress in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Smart Mattress in these regions. 

This research report categorizes the global Smart Mattress market by top players/brands, region, type and end user. This report also studies the global Smart Mattress market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company: 
Sleep Number 
Eight 
ReST 
Kingsdown

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3349369-global-smart-mattress-market-insights-forecast-to-2025

Market size by Product 
60 inches 
Market size by End User 
Residential 
Commercial

Market size by Region 
North America 
United States 
Canada 
Mexico 
Asia-Pacific 
China 
India 

The study objectives of this report are: 
To study and analyze the global Smart Mattress market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. 
To understand the structure of Smart Mattress market by identifying its various subsegments. 
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). 
Focuses on the key global Smart Mattress companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. 
To project the value and sales volume of Smart Mattress submarkets, with respect to key regions. 
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Leave a Query @ https://www.wiseguyreports.com/enquiry/3349369-global-smart-mattress-market-insights-forecast-to-2025

Table of Content

Table of Contents

1 Study Coverage 
1.1 Smart Mattress Product 
1.2 Market Segments 
1.3 Key Manufacturers Covered 
1.4 Market by Type 
1.4.1 Global Smart Mattress Market Size Growth Rate by Product 
1.4.2 60 inches 
1.5 Market by End User 
1.5.1 Global Smart Mattress Market Size Growth Rate by End User 
1.5.2 Residential 
1.5.3 Commercial 
1.6 Study Objectives 
1.7 Years Considered

11 Company Profiles 
11.1 Sleep Number 
11.1.1 Sleep Number Company Details 
11.1.2 Company Business Overview 
11.1.3 Sleep Number Smart Mattress Sales, Revenue and Gross Margin (2014-2019) 
11.1.4 Sleep Number Smart Mattress Products Offered 
11.1.5 Sleep Number Recent Development 
11.2 Eight 
11.2.1 Eight Company Details 
11.2.2 Company Business Overview 
11.2.3 Eight Smart Mattress Sales, Revenue and Gross Margin (2014-2019) 
11.2.4 Eight Smart Mattress Products Offered 
11.2.5 Eight Recent Development 
11.3 ReST 
11.3.1 ReST Company Details 
11.3.2 Company Business Overview 
11.3.3 ReST Smart Mattress Sales, Revenue and Gross Margin (2014-2019) 
11.3.4 ReST Smart Mattress Products Offered 
11.3.5 ReST Recent Development 
11.4 Kingsdown 
11.4.1 Kingsdown Company Details 
11.4.2 Company Business Overview 
11.4.3 Kingsdown Smart Mattress Sales, Revenue and Gross Margin (2014-2019) 
11.4.4 Kingsdown Smart Mattress Products Offered 
11.4.5 Kingsdown Recent Development

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3349369

Continued…                       

 

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire